Cargando…

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study

OBJECTIVES: To estimate additional spending if NHS England paid the same prices as US Medicare Part D for the 50 single-source brand-name drugs with the highest expenditure in English primary care in 2018. DESIGN: Retrospective analysis of 2018 drug prescribing and spending in the NHS England prescr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Michael, MacKenna, Brian, Feldman, William B, Walker, Alex J, Avorn, Jerry, Kesselheim, Aaron S, Goldacre, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488930/ https://www.ncbi.nlm.nih.gov/pubmed/32910868 http://dx.doi.org/10.1177/0141076820918238

Ejemplares similares

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Competition and price among brand-name drugs in the same class: A systematic review of the evidence
por: Sarpatwari, Ameet, et al.
Publicado: (2019)

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
por: Rome, Benjamin N., et al.
Publicado: (2021)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019)

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021)

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims
por: Desai, Rishi J., et al.
Publicado: (2019)

Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care
por: Curtis, Helen J, et al.
Publicado: (2020)

Clinicians’ Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation
por: Kesselheim, Aaron S., et al.
Publicado: (2014)

Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration
por: Hong, Song Hee, et al.
Publicado: (2005)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
por: MacKenna, Brian, et al.
Publicado: (2020)

Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
por: Austad, Kirsten E., et al.
Publicado: (2011)

Public sector financial support for late stage discovery of new drugs in the United States: cohort study
por: Nayak, Rahul K, et al.
Publicado: (2019)

Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021
por: Roberts, Thomas J., et al.
Publicado: (2023)

Brand Suicide? Memory and Liking of Negative Brand Names
por: Guest, Duncan, et al.
Publicado: (2016)

US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
por: Lalani, Hussain S, et al.
Publicado: (2023)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care
por: MacKenna, Brian, et al.
Publicado: (2020)

Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
por: Kesselheim, Aaron S., et al.
Publicado: (2012)

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015)

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
por: Zhai, Mike Z., et al.
Publicado: (2022)

Brands, networks, communities: How brand names are wired in the mind
por: Kovács, László, et al.
Publicado: (2022)

Are brand names special words? Letter visual‐similarity affects the identification of brand names, but not common words
por: Perea, Manuel, et al.
Publicado: (2022)

Not as bad as you think: a comparison of the nutrient content of best price and brand name food products in Switzerland
por: Khalatbari-Soltani, Saman, et al.
Publicado: (2016)

Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition
por: Zhang, James X.
Publicado: (2020)

An ERP-study of brand and no-name products
por: Thomas, Anika, et al.
Publicado: (2013)

Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
por: Bothwell, Laura E, et al.
Publicado: (2018)

Public funding for transformative drugs: the case of sofosbuvir
por: Barenie, Rachel E., et al.
Publicado: (2021)

Hello, my name is awesome: how to create brand names that stick
por: Watkins, Alexandra
Publicado: (2019)

What's in and what's out in branding? A novel articulation effect for brand names
por: Topolinski, Sascha, et al.
Publicado: (2015)

Price perception and price appearance on repurchase intention of Gen Y: do brand experience and brand preference mediate?
por: Yasri, Yasri, et al.
Publicado: (2020)

Branded prescription drug spending: a framework to evaluate policy options
por: Ballreich, Jeromie, et al.
Publicado: (2017)

Outcomes of the 340B Drug Pricing Program: A Scoping Review
por: Knox, Ryan P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_at0ds6ncvpldt1144j1qoi4kuc